decentralised clinical trials Archives -

After a long period of not much change, clinical trials are undergoing several massive shifts. At the American

To increase clinical trial diversity, build trust in communities and use tech wisely

https://pharmaphorum.com/patients/increase-clinical-trial-diversity-build-trust-in-communities-use-tech-wisely/

Reify Health has completed fourth-round financing that adds $220 million to its cash reserves and pushes its valuation

Financing pushes value of clinical trial tech firm Reify to $4.8bn

https://pharmaphorum.com/news/financing-pushes-value-of-clinical-trial-tech-firm-reify-to-4-8bn/

Just over a year after partnering on a project to accelerate recruitment into decentralised clinical trials (DCTs), Thread

Thread builds in decentralised trials again with CureClick buy

https://pharmaphorum.com/news/thread-builds-in-decentralised-trials-again-with-cureclick-buy/

AstraZeneca has bought a stake in digital health firm Huma Therapeutics in a deal that will see ownership

AZ expands digital health plans with Huma alliance

https://pharmaphorum.com/news/az-expands-digital-health-plans-with-huma-alliance/

Prescription digital therapeutics (DTx) company Blue Note is starting a large-scale, decentralised trial of two cancer therapies that

With Curebase’s help, Blue Note starts virtual trial of cancer DTx

https://pharmaphorum.com/news/with-curebases-help-blue-note-starts-virtual-trial-of-cancer-dtx/

“Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare

Importance of diversity in pharma and clinical trials

https://pharmaphorum.com/r-d/importance-diversity-pharma-and-clinical-trials-impetus/

Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream. Now,

Assumptions to evidence: How NIHR project is solidifying UK’s remote trial know how

https://pharmaphorum.com/r-d/assumptions-to-evidence-ninr-solidifying-uk-remote-trial/

decentralised clinical trials